These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3898826)

  • 1. Potassium supplementation via the dialysate in continuous ambulatory peritoneal dialysis.
    Spital A; Sterns RH
    Am J Kidney Dis; 1985 Sep; 6(3):173-6. PubMed ID: 3898826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A quantitative description of solute and fluid transport during peritoneal dialysis.
    Heimbürger O; Waniewski J; Werynski A; Lindholm B
    Kidney Int; 1992 May; 41(5):1320-32. PubMed ID: 1614047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Icodextrin and 2.5% Glucose in Potassium Metabolism by Acute K load via Dialysate in Continuous Ambulatory Peritoneal Dialysis Patients.
    Yi JH; Yun YW; Han SW; Kim HJ
    Electrolyte Blood Press; 2009 Jun; 7(1):25-30. PubMed ID: 21468182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Profound hypokalemia in continuous ambulatory peritoneal dialysis.
    Rostand SG
    Arch Intern Med; 1983 Feb; 143(2):377-8. PubMed ID: 6824407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcium mass transfer in peritoneal dialysis patients using 2.5 mEq/l calcium dialysate.
    Piraino B; Bernardini J; Holley J; Johnston JR; Perlmutter JA; Martis L
    Clin Nephrol; 1992 Jan; 37(1):48-51. PubMed ID: 1541065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized, double-blind, placebo-controlled trial of spironolactone for hypokalemia in continuous ambulatory peritoneal dialysis patients.
    Yongsiri S; Thammakumpee J; Prongnamchai S; Tengpraettanakorn P; Chueansuwan R; Tangjaturonrasme S; Dinchuthai P
    Ther Apher Dial; 2015 Feb; 19(1):81-6. PubMed ID: 25196890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of dialysate glucose load on plasma glucose and glucoregulatory hormones in CAPD patients.
    Armstrong VW; Creutzfeldt W; Ebert R; Fuchs C; Hilgers R; Scheler F
    Nephron; 1985; 39(2):141-5. PubMed ID: 3883205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical parameters, nutritional status and efficiency of dialysis in CAPD and CCPD patients.
    Gao H; Lew SQ; Bosch JP
    Am J Nephrol; 1999; 19(1):7-12. PubMed ID: 10085443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraperitoneal insulin in uraemic diabetics undergoing continuous ambulatory peritoneal dialysis.
    Balducci A; Slama G; Rottembourg J; Baumelou A; Delage A
    Br Med J (Clin Res Ed); 1981 Oct; 283(6298):1021-3. PubMed ID: 6794746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of an Intravenous Potassium Dosing Algorithm for Hypokalemic Critically Ill Patients.
    Johnston CT; Maish GO; Minard G; Croce MA; Dickerson RN
    JPEN J Parenter Enteral Nutr; 2017 Jul; 41(5):796-804. PubMed ID: 26304602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low dialysate calcium in continuous ambulatory peritoneal dialysis: a randomized controlled multicenter trial. The Peritoneal Dialysis Multicenter Study Group.
    Weinreich T; Passlick-Deetjen J; Ritz E
    Am J Kidney Dis; 1995 Mar; 25(3):452-60. PubMed ID: 7872324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intra-peritoneal administration of potassium and magnesium: a practical method to supplement these electrolytes in peritoneal dialysis patients.
    Amirmokri P; Morgan P; Bastani B
    Ren Fail; 2007; 29(5):603-5. PubMed ID: 17654324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of Potassium Supplementation in Hypokalemic Patients Receiving Peritoneal Dialysis: A Randomized Controlled Trial.
    Pichitporn W; Kanjanabuch T; Phannajit J; Puapatanakul P; Chuengsaman P; Parapiboon W; Treamtrakanpon W; Boonyakrai C; Matayart S; Katavetin P; Perl J; Praditpornilpa K; Eiam-Ong S; Tungsanga K; Johnson DW
    Am J Kidney Dis; 2022 Nov; 80(5):580-588.e1. PubMed ID: 35597332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of peritoneal glucose load on plasma leptin concentration in continuous ambulatory peritoneal dialysis patients.
    Kim MJ; Kim GA; Lee SW; Song JH; Hyun IY
    Yonsei Med J; 2000 Aug; 41(4):485-90. PubMed ID: 10992810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low sodium concentration solution in normohydrated CAPD patients.
    Amici G; Virga G; Da Rin G; Teodori T; Calzavara P; Bocci C
    Adv Perit Dial; 1995; 11():78-82. PubMed ID: 8534744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of cefotaxime in patients undergoing haemodialysis and continuous ambulatory peritoneal dialysis.
    Hasegawa H; Imada A; Horiuchi A; Nishii Y; Fukushima M; Kurokawa E
    J Antimicrob Chemother; 1984 Sep; 14 Suppl B():135-42. PubMed ID: 6094432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ciprofloxacin in plasma and peritoneal dialysate after oral therapy in patients on continuous ambulatory peritoneal dialysis.
    Fleming LW; Moreland TA; Scott AC; Stewart WK; White LO
    J Antimicrob Chemother; 1987 Apr; 19(4):493-503. PubMed ID: 3583969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between the serum parathyroid hormone and magnesium levels in continuous ambulatory peritoneal dialysis (CAPD) patients using low-magnesium peritoneal dialysate.
    Cho MS; Lee KS; Lee YK; Ma SK; Ko JH; Kim SW; Kim NH; Choi KC
    Korean J Intern Med; 2002 Jun; 17(2):114-21. PubMed ID: 12164088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abdominal pains during CAPD with acetate buffered dialysate.
    Ahlmén J; Stelin G
    Lancet; 1983 Nov; 2(8361):1247. PubMed ID: 6139586
    [No Abstract]   [Full Text] [Related]  

  • 20. Dialysate to plasma solute concentration (D/P) versus peritoneal transport parameters in CAPD.
    Heimbürger O; Waniewski J; Werynski A; Park MS; Lindholm B
    Nephrol Dial Transplant; 1994; 9(1):47-59. PubMed ID: 8177476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.